249 related articles for article (PubMed ID: 11474260)
41. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
[TBL] [Abstract][Full Text] [Related]
42. Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview.
Barber FD; Mavligit G; Kurzrock R
Cancer Treat Rev; 2004 Aug; 30(5):425-36. PubMed ID: 15245775
[TBL] [Abstract][Full Text] [Related]
43. Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity.
Davidson BS; Izzo F; Chase JL; DuBrow RA; Patt Y; Hohn DC; Curley SA
Am J Surg; 1996 Sep; 172(3):244-7. PubMed ID: 8862076
[TBL] [Abstract][Full Text] [Related]
44. Hepatic artery infusion pump for nasopharyngeal carcinoma with liver metastasis.
Peng C; Zhou C; Li G; Li H; Shi L
Clin Exp Metastasis; 2020 Apr; 37(2):333-339. PubMed ID: 31863241
[TBL] [Abstract][Full Text] [Related]
45. Robotic-Assisted Placement of an Hepatic Artery Infusion Pump and Catheter for Regional Chemotherapy of the Liver.
Dhir M; Magge D; Novak S; Bartlett DL; Zureikat AH
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):755-756. PubMed ID: 27495280
[TBL] [Abstract][Full Text] [Related]
46. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
47. Comparison of complete pathologic response and hepatic injuries between hepatic arterial infusion and systemic administration of oxaliplatin in patients with colorectal liver metastases.
Allard MA; Sebagh M; Baillie G; Lemoine A; Dartigues P; Faitot F; Faron M; Boige V; Vitadello F; Vibert E; Elias D; Adam R; Goéré D; Sa Cunha A
Ann Surg Oncol; 2015; 22(6):1925-32. PubMed ID: 25448804
[TBL] [Abstract][Full Text] [Related]
48. Percutaneous vs. surgical placement of hepatic artery indwelling catheters for regional chemotherapy.
Aldrighetti L; Arru M; Angeli E; Venturini M; Salvioni M; Ronzoni M; Caterini R; Ferla G
Hepatogastroenterology; 2002; 49(44):513-7. PubMed ID: 11995485
[TBL] [Abstract][Full Text] [Related]
49. Outcomes of a Phase I/II Trial of Hepatic Arterial Infusion of Oxaliplatin Combined with Intravenous 5-Fluorouracil and l-Leucovorin in Patients with Unresectable Liver Metastases from Colorectal Cancer After Systemic Chemotherapy Failure.
Sato Y; Inaba Y; Ura T; Nishiofuku H; Yamaura H; Kato M; Takahari D; Tanaka T; Muro K
J Gastrointest Cancer; 2018 Jun; 49(2):132-137. PubMed ID: 28058527
[TBL] [Abstract][Full Text] [Related]
50. Hepatic arterial infusion chemotherapy by the fixed-catheter-tip method: retrospective comparison of percutaneous left subclavian and femoral port-catheter system implantation.
Matsumoto T; Yamagami T; Yoshimatsu R; Morishita H; Kitamura N; Sato O; Hasebe T
AJR Am J Roentgenol; 2014 Jan; 202(1):211-5. PubMed ID: 24370146
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant hepatic arterial infusion after curative resection of colorectal liver metastases using removable intra-arterial catheters with shape-memory alloy.
Tono T; Kanoh T; Ohnishi T; Matsushita M; Nakano Y; Kimura Y; Iwazawa T; Yano H; Okamura J; Monden T
J Surg Oncol; 2004 Dec; 88(4):248-55. PubMed ID: 15565591
[TBL] [Abstract][Full Text] [Related]
52. Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer.
Mocellin S; Pasquali S; Nitti D
Cochrane Database Syst Rev; 2009 Jul; (3):CD007823. PubMed ID: 19588444
[TBL] [Abstract][Full Text] [Related]
53. Transaxillary access to perform hepatic artery infusion (HAI) for secondary or primitive hepatic tumors.
Zanon C; Grosso M; Zanon E; Veltri A; Alabiso O; Bazzan M; Chiappino I; Mussa A
Minerva Chir; 1996 Sep; 51(9):755-8. PubMed ID: 8968147
[TBL] [Abstract][Full Text] [Related]
54. Percutaneous implantation of arterial Port-a-cath via trans-subclavin access.
Zanon C; Grosso M; Clara R; Chiappino I; Mancini A; Mussa A
Anticancer Res; 1999; 19(6C):5667-71. PubMed ID: 10697638
[TBL] [Abstract][Full Text] [Related]
55. [Hepatic arterial infusion chemotherapy using totally implantable reservoir in liver metastases in colorectal cancer].
Akamatsu H; Kodaira S; Teramoto T; Arisawa Y; Takabayashi T; Nakayama T; Abe O
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2884-8. PubMed ID: 2782894
[TBL] [Abstract][Full Text] [Related]
56. Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.
Cercek A; Boucher TM; Gluskin JS; Aguiló A; Chou JF; Connell LC; Capanu M; Reidy-Lagunes D; D'Angelica M; Kemeny NE
J Surg Oncol; 2016 Nov; 114(6):655-663. PubMed ID: 27566258
[TBL] [Abstract][Full Text] [Related]
57. [Prehepatectomy chemotherapy using hepatic artery infusion plus systemic chemotherapy for liver metastases from colorectal cancer].
Tanaka K; Kumamoto T; Nojiri K; Mori R; Matsuyama R; Takeda K; Ota M; Akiyama H; Ichikawa Y; Endo I
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2267-70. PubMed ID: 21224543
[TBL] [Abstract][Full Text] [Related]
58. Adjuvant regional chemotherapy after hepatic resection for colorectal metastases.
Ambiru S; Miyazaki M; Ito H; Nakagawa K; Shimizu H; Nakajima N
Br J Surg; 1999 Aug; 86(8):1025-31. PubMed ID: 10460638
[TBL] [Abstract][Full Text] [Related]
59. Hepatic artery infusion chemotherapy for metastatic colorectal carcinoma.
Koea JB; Kemeny N
Semin Surg Oncol; 2000; 19(2):125-34. PubMed ID: 11126377
[TBL] [Abstract][Full Text] [Related]
60. Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program.
Walker BS; Billingsley KG; Sutton TL; Kolbeck KJ; Korngold EK; Nabavizadeh N; Dewey EN; Herzig DO; Lopez CD; Mayo SC
J Surg Oncol; 2022 Sep; 126(3):513-522. PubMed ID: 35522249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
